NCT04404972

Brief Summary

The purpose of the study is to describe the incidence of complications in brain death adult organ donors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 28, 2020

Completed
1.8 years until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

1.7 years

First QC Date

May 22, 2020

Last Update Submit

March 27, 2023

Conditions

Keywords

Brain DeathOrgan Donation

Outcome Measures

Primary Outcomes (10)

  • Hypotension

    Hypotension is defined as increase of vasoactive drug dose by 20% or systolic blood pressure lower than 90 mmHg or need for fluid resuscitation after initial normovolemia was achieved

    48hours prior confirmation of brain death to ICU discharge

  • Serum lactate level

    Maximal lactate level will be evaluated during ICU stay

    48hours prior confirmation of brain death to ICU discharge

  • Catecholamine storm

    Catecholamine storm is defined as onset of tachycardia and/or hypertension

    48hours prior confirmation of brain death to ICU discharge

  • Myocardial dysfunction

    Myocardial dysfunction is defined as left ventricle ejection fraction under 50% on trans-thoracic echocardiography or S-T segment depression or elevation or T wave negativity or positive troponin serum level

    48hours prior confirmation of brain death to ICU discharge

  • ARDS

    ARDS is defined and stratified according to Berlin definition

    48hours prior confirmation of brain death to ICU discharge

  • Oxygenation index

    Oxygenation index will be calculated as PaO2 divided by FiO2

    48hours prior confirmation of brain death to ICU discharge

  • Diabetes insipidus

    Diabetes insipidus is defines as urine output more than 4ml/kg per hour or urine specific gravity under 1010

    48hours prior confirmation of brain death to ICU discharge

  • Renal dysfunction

    Renal dysfunction is defined as presence of at least one of these criteria: absolute increase in serum creatinine ≥0.3 mg/dL (≥26.4 μmol/L) or increase in serum creatinine ≥1.5x above baseline or oliguria (urine output \<0.5 mL/kg per hour) for \>6 hours

    48hours prior confirmation of brain death to ICU discharge

  • Coagulopathy

    Coagulopathy is defined as international normalised ratio above 1,5 or platelet count below 100 000 per microliter

    48hours prior confirmation of brain death to ICU discharge

  • Hypothermia

    Body temperature below 36°C or need for external warming

    48hours prior confirmation of brain death to ICU discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult critically ill patinets with confirmed brain death admitted to university hospital who become brain death organ donor.

You may qualify if:

  • age ≥18 years
  • confirmed brain death
  • organ donor

You may not qualify if:

  • \- age under 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Brno

Brno, 62500, Czechia

RECRUITING

MeSH Terms

Conditions

Brain Death

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Roman Gal, MD, PhD

    University Hospital Brno

    STUDY CHAIR

Central Study Contacts

Ondrej Hrdy, MD

CONTACT

Viktor Agalarev, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 22, 2020

First Posted

May 28, 2020

Study Start

April 1, 2022

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations